It’s More Than a Career, It’s a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day. Our Mission People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world. About Sarah Cannon Research Institute (SCRI) Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients for more than three decades, SCRI is a leader in drug development. We have conducted more than 800 first-in-human clinical trials since our inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. In 2022, HCA Heathcare and McKesson announced a joint venture combining McKesson’s US Oncology Research and HCA’s SCRI to advance cancer care and expand access to onology clinical research. With 51% ownership, McKesson assumed operating control and both parties are actively engaged in strategic oversight and governance, including the Board. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients to clinical trials at more than 250 locations in 24 states across the U.S. SCRI offers end-to-end clinical trial site management, contract research services for biopharma and personalized medicine advisory services in one place: Our Site Management Organization (SMO) delivers operational, regulatory and other centralized research support services for industry-sponsored and investigator-initiated trials. SCRI Development Innovations, our global, full-service Contract Research Organization (CRO) works in concert with SCRI's SMO, specializing in oncology clinical development services from first-in-human studies to regulatory approval. Our Personalized Medicine program transforms real-world data into actionable insights so we can match the right therapy to the right patient at the right time. Driven by our commitment to expanding clinical trial access, we are finding new ways to remove barriers and ensure patients receive the cutting-edge therapies they need. The Role The Chief Financial Officer (CFO) is accountable for the administrative, financial, and risk management operations of Sarah Cannon. The CFO will serve as the chief financial spokesperson and will oversee all strategic and tactical matters as they relate to budget management, cost analysis, accounting and forecasting needs. The CFO will facilitate internal alignment and drive key negotiations with suppliers, customers, and partnership opportunities. As a member of the executive team, the CFO provides input on operations and the overall direction of the company. These responsibilities are applicable to: Sarah Cannon Research Institute including the Site Support Organization, Development Innovations, and all supporting organizations. Additionally, the CFO supports a network of formal and informal relationships that range from potential acquisitions or contracted partnerships to joint ventures and merged entities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Number of Employees
5,001-10,000 employees